Regulations.gov document
Response to CDER for Suspension of ANDA Approval from Armenpharm, Ltd
Other · FDA-2011-P-0081 · posted Dec 24, 2015
Key facts
| Document ID | FDA-2011-P-0081-0014 |
|---|---|
| Title | Response to CDER for Suspension of ANDA Approval from Armenpharm, Ltd |
| Document type | Other |
| Subtype | Response(s) |
| Agency | FDA |
| Docket | FDA-2011-P-0081 |
| Posted | Dec 24, 2015 |
| Comment period opens | Dec 24, 2015 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: